Your browser doesn't support javascript.
loading
Three-Year Clinical Outcomes of the Innova™ Self-Expanding Nitinol Stent for the Treatment of Femoropopliteal Lesions.
Karashima, Eiji; Takahara, Mitsuyoshi; Hozawa, Koji; Yamauchi, Yasutaka; Suzuki, Kenji; Suematsu, Nobuhiro; Miyashita, Yusuke; Enomoto, Soichiro; Tokuyama, Hideo; Murata, Naotaka; Haraguchi, Kazuki; Soga, Yoshimitsu.
Afiliación
  • Karashima E; Department of Cardiology, Shimonoseki City Hospital, 1-13-1 Kouyou-chou, Shimonoseki, Yamaguchi, 750-8520, Japan. ekarashima@yahoo.co.jp.
  • Takahara M; Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
  • Hozawa K; Department of Cardiology, New Tokyo Hospital, Matsudo, Japan.
  • Yamauchi Y; Cardiovascular Center, Takatsu General Hospital, Kanagawa, Japan.
  • Suzuki K; Department of Cardiology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Suematsu N; Department of Cardiology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
  • Miyashita Y; Department of Cardiology, Nagano Red Cross Hospital, Nagano, Japan.
  • Enomoto S; Department of Cardiology, Tenri Hospital, Tenri, Japan.
  • Tokuyama H; Department of Cardiology, Kawaguchi Cardiovascular and Respiratory Hospital, Kawaguchi, Japan.
  • Murata N; Department of Cardiology, Tokyo Medical University Hospital, Tokyo, Japan.
  • Haraguchi K; Division of Cardiovascular Medicine, Cardiovascular Center, Shin-Koga Hospital, Kurume, Japan.
  • Soga Y; Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
Cardiovasc Intervent Radiol ; 44(11): 1722-1727, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34523023
PURPOSE: To report the 3-year results of Innova™ stent implantation for the treatment of femoropopliteal (FP) lesions in a real-world setting. METHODS: This single-arm, retrospective, multicenter clinical study analyzed 481 lesions from 453 consecutive patients with symptomatic peripheral artery diseases (Rutherford category 1-6) who underwent endovascular therapy with implantation of Innova™ self-expanding nitinol stent for FP lesions. The primary outcome measure was the 3-year restenosis rate based on doppler-ultrasound or angiographic criteria. The secondary outcome measures included the rates of 3-year major amputation and major adverse limb events. RESULTS: Restenosis following Innova™ implantation was found in 61% of the cases at 3 years. At the end of 3 years, the rates of major amputations and major adverse limb events were 3 and 31%, respectively. In cases free from restenosis at 1 year, no predictive factors for restenosis at 3 years could be determined. CONCLUSION: The present study demonstrated mid-term clinical outcomes after Innova™ stent implantation for the treatment of FP lesions in a real-world population. The Innova™ stent demonstrated acceptable clinical outcomes in a real-world setting.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Arteria Poplítea / Enfermedad Arterial Periférica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Arteria Poplítea / Enfermedad Arterial Periférica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos